1-5 of 5
Rajasekhar NVS Suragani, PhD
Close
Sort by
Journal Articles

Genetic Investigation of the Role of GDF11 in the Treatment of β-Thalassemia and MDS

Paraskevi Rea Oikonomidou, MD, Ping La, PhD, Ritama Gupta, MSc, Vania Lo Presti, Carla Casu, PhD, Laura Breda, PhD, Deborah Watson, PhD, Rajasekhar NVS Suragani, PhD, Ravindra Kumar, PhD, Stefano Rivella, PhD
Journal: Blood
Blood (2016) 128 (22): 2439.
https://doi.org/10.1182/blood.V128.22.2439.2439
Published: 2016
Journal Articles

Rap-536 (Murine ACE-536/Luspatercept) Inhibits Smad2/3 Signaling and Promotes Erythroid Differentiation By Restoring GATA-1 Function in Murine b-Thalassemia

Pedro A. Martinez, PhD, Rajasekhar NVS Suragani, PhD, Manoj Bhasin, PhD, Robert Li, Robert Scott Pearsall, PhD, Ravindra Kumar, PhD
Journal: Blood
Blood (2015) 126 (23): 751.
https://doi.org/10.1182/blood.V126.23.751.751
Published: 2015
Journal Articles

TGFb1 Antagonist Inhibits Fibrosis in a Murine Model of Myelofibrosis

Rajasekhar NVS Suragani, PhD, Pedro A. Martinez, PhD, Sharon M Cawley, PhD, Robert Li, Robert Scott Pearsall, PhD, Ravindra Kumar, PhD
Journal: Blood
Blood (2015) 126 (23): 605.
https://doi.org/10.1182/blood.V126.23.605.605
Published: 2015
Journal Articles

Modified Actriib-Fc Fusion Protein (ACE-536) Mitigates Sickling and Red Cell Pathology in a Murine Model of Sickle Cell Disease

Rajasekhar NVS Suragani, PhD, Robert Li, Sharon M Cawley, R. Scott Pearsall, Ravindra Kumar
Journal: Blood
Blood (2014) 124 (21): 4055.
https://doi.org/10.1182/blood.V124.21.4055.4055
Published: 2014
Journal Articles

Modified Activin Receptor Type IIb-Fc Fusion Protein (RAP-536) Decreases Anemia In a Murine Model Of Myelodysplastic Syndrome and Improves Overall Survival

Rajasekhar NVS Suragani, PhD, Robert Li, Sharon Cawley, R. Scott Pearsall, Ph.D., Ravi Kumar, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 749.
https://doi.org/10.1182/blood.V122.21.749.749
Published: 2013